[Edaily Reporter KYUNG GYEYOUNG ] AMOREPACIFIC CORPORATION is accelerating its efforts to achieve 15 trillion won in revenue by 2035 by expanding its global footprint, with a focus on derma beauty and hair care.

AMOREPACIFIC CORPORATION(090430)The company announced on the 14th that it held its “2026 Investor Day” on the 11th at its headquarters in Yongsan-gu, Seoul, for major domestic and international institutional investors and securities firm analysts. Last year, marking its 80th anniversary, AMOREPACIFIC CORPORATION announced its mid-to-long-term goal of 15 trillion won in revenue by 2035, alongside its “Create New Beauty” initiative. At this Investor Day, the company unveiled specific strategies and a roadmap to achieve this goal.

AMOREPACIFIC CORPORATION announced on that day that it aims to expand its global business, centered on Estra and Ilyoon, to surpass 1 trillion won in sales for its derma-beauty brands by the 2030 fiscal year (July 2029–June 2030). Estra plans to expand into 9 additional countries by the first half of next year, building on its presence in 36 countries, led by its flagship product, “Atobariere 365.” Ilyoon, which focuses on its flagship product “Ato Cream” containing ceramides, intends to pursue growth centered on key digital channels, such as raising brand awareness through social media.

IOPE, a clinical-grade skincare brand, is strengthening its competitiveness by leveraging expertise derived from research into dermatological procedures and products formulated with highly effective ingredients such as PDRN and retinol. Building on its entry into Sephora in the U.S., IOPE plans to expand into Europe in the first half of next year. The brand aims to grow into a 500 billion won business by 2035.

Hair care was identified as another key growth driver for AMOREPACIFIC CORPORATION. Noh Byung-kwon, Head of the Hair & Beauty Unit (Vice President) at AMOREPACIFIC CORPORATION, announced plans to achieve 1 trillion won in hair care sales by fiscal year 2030, building on a multi-brand portfolio that includes Ryeo, Mise-en-Scène, Labo H, Longtake, Ayunchae, and Amos Professional. The company also plans to expand its business in the U.S., China, Japan, and Brazil to increase the share of global sales to over 60%.

In addition, AMOREPACIFIC CORPORATION intends to accelerate growth by expanding consumer touchpoints through key digital channels such as social media and e-commerce, and by replicating successful models from specific brands and markets across the global market. The company has set targets for the 2027 fiscal year (July 2026–June 2027) of 10% revenue growth and an operating profit margin of at least 11%. The company plans to expand its business in key regions such as the Americas, Europe, and Japan, while intensively growing high-potential sectors—including derma beauty, clinical skincare, and hair care—to boost both growth and profitability.

Kim Seung-hwan, CEO of AMOREPACIFIC CORPORATION, stated, “We will accelerate the growth of our existing flagship brands and cultivate derma beauty, clinical skincare, and hair care as new global growth engines.” He added, “We will further solidify our core competitive strengths—brand value, technological capabilities, and quality—and achieve sustainable growth in the global market by responding agilely to changes in customers and the market driven by social media, e-commerce, and AI.”